loadpatents
Patent applications and USPTO patent grants for BREDER; Christopher D..The latest application filed is for "method of treatment of attention deficit/hyperactivity disorder (adhd)".
Patent | Date |
---|---|
Method Of Treatment Of Attention Deficit/hyperactivity Disorder (adhd) App 20220233548 - BREDER; Christopher D. | 2022-07-28 |
Method of treatment of attention deficit/hyperactivity disorder (ADHD) Grant 11,324,753 - Breder May 10, 2 | 2022-05-10 |
Method Of Treatment Of Cns Disorders App 20200069653 - Breder; Christopher D. | 2020-03-05 |
Method Of Treatment Of Aggression App 20200022986 - BREDER; Christopher D. | 2020-01-23 |
Method of treatment of aggression Grant 10,201,547 - Breder Feb | 2019-02-12 |
Method Of Treatment Of Aggression App 20180325912 - BREDER; Christopher D. | 2018-11-15 |
Method of treatment of aggression Grant 10,058,556 - Breder August 28, 2 | 2018-08-28 |
Method Of Treatment Of Aggression App 20180055853 - BREDER; Christopher D. | 2018-03-01 |
Method of treatment of aggression Grant 9,801,887 - Breder October 31, 2 | 2017-10-31 |
Method Of Treatment Of Attention Deficit/hyperactivity Disorder (adhd) App 20170266195 - BREDER; Christopher D. | 2017-09-21 |
Method Of Treatment Of Cns Disorders App 20160136135 - Breder; Christopher D. | 2016-05-19 |
Method Of Treatment Of Attention Deficit/hyperactivity Disorder (adhd) App 20150290202 - BREDER; Christopher D. | 2015-10-15 |
Method Of Treatment Of Aggression App 20140187552 - Breder; Christopher D. | 2014-07-03 |
Method Of Treatment Of Attention Deficit/hyperactivity Disorder (adhd) App 20130289035 - Breder; Christopher D. | 2013-10-31 |
Method Of Treatment Of Cns Disorders App 20120302615 - Breder; Christopher D. | 2012-11-29 |
Method Of Treatment Of Depression App 20120115871 - Breder; Christopher D. | 2012-05-10 |
Pharmaceutical combinations of oxycodone and naloxone Grant 7,943,173 - Breder , et al. May 17, 2 | 2011-05-17 |
Method of treatment of aggression App 20100173907 - Breder; Christopher D. | 2010-07-08 |
Method of treatment of attention deficit/hyperactivity disorder (ADHD) App 20100069390 - Breder; Christopher D. | 2010-03-18 |
Pharmaceutical combinations of oxycodone and naloxone App 20030069263 - Breder, Christopher D. ;   et al. | 2003-04-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.